Freedman, S., Hercinovic, A., Wallace, D. K., Kraker, R., Li, Z., Bhatt, A., et al. (2022). Low- and Very Low-Dose Bevacizumab for Retinopathy of Prematurity: Reactivations, Additional Treatments, and 12-Month Outcomes. Ophthalmology, 129(10), 1120-1128. 10.1016/j.ophtha.2022.05.019(Original work published 2022)
